Jazz Pharmaceuticals (JAZZ) Common Equity (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) reported Common Equity of $4.8 billion for Q2 2026, up 29.6% from $3.71 billion a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Jazz Pharmaceuticals posted Common Equity of $4.32 billion, up 5.5% from FY2024.
- Common Equity has increased for three consecutive years, with a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- By year, Common Equity came in at $4.09 billion in FY2024 (+9.5%), $3.74 billion in FY2023 (+21.1%), $3.09 billion in FY2022 (-22.2%) and $3.97 billion in FY2021 (+8.3%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q4 2010.
- Year over year, Common Equity has now increased in each of the last three quarters, with growth averaging 9.9% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q2 2026 (growth of 29.6%); the low point was Q3 2022 (a decline of 30.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.53 billion (Q1 2026), $4.32 billion (Q4 2025) and $3.96 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn | 4.80 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.80 Bn |
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.32 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 3.71 Bn |
| Mar 31, 2025 | 4.17 Bn |
| Dec 31, 2024 | 4.09 Bn |
| Sep 30, 2024 | 4.17 Bn |
| Jun 30, 2024 | 3.76 Bn |
| Mar 31, 2024 | 3.70 Bn |
| Dec 31, 2023 | 3.74 Bn |
| Sep 30, 2023 | 3.49 Bn |
| Jun 30, 2023 | 3.53 Bn |
| Mar 31, 2023 | 3.34 Bn |
| Dec 31, 2022 | 3.09 Bn |
| Sep 30, 2022 | 2.75 Bn |
| Jun 30, 2022 | 3.20 Bn |
| Mar 31, 2022 | 3.61 Bn |
| Dec 31, 2021 | 3.97 Bn |
| Sep 30, 2021 | 3.94 Bn |
API Access
Jazz Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();